359 filings
Page 2 of 18
4
wi1u k2p5h
3 Jan 24
Change in insider ownership
4:27pm
SC 13G/A
jm1066 dm0nzzyr9
2 Jan 24
AVENUE THERAPEUTICS / SABBY MANAGEMENT ownership change
3:45pm
SC 13G/A
7p4vv21
13 Dec 23
AVENUE THERAPEUTICS / Davidow Robert L ownership change
4:03pm
4
0z5hew
13 Dec 23
AVENUE THERAPEUTICS / Robert L Davidow ownership change
4:02pm
SC 13G
3c19mw2ww
28 Nov 23
AVENUE THERAPEUTICS / Davidow Robert L ownership change
4:05pm
3
23w y07nrr3we88mt
28 Nov 23
AVENUE THERAPEUTICS / Robert L Davidow ownership change
4:01pm
8-K
kexbx4
24 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:19pm
8-K
gb3ospc6dk797psn7
13 Nov 23
Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
4:10pm
8-K
ib1fb97 jq
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
jnlw6hcp
2 Nov 23
Prospectus supplement with pricing info
9:00am
EFFECT
wjbsxt0u
1 Nov 23
Notice of effectiveness
12:15am
CORRESP
nu8o63u
30 Oct 23
Correspondence with SEC
12:00am
CORRESP
76sdqn2k
30 Oct 23
Correspondence with SEC
12:00am
CORRESP
uea368uazjezkg1 2y4w
27 Oct 23
Correspondence with SEC
12:00am
CORRESP
vjz tvcjb68g10xa
27 Oct 23
Correspondence with SEC
12:00am
CORRESP
55lptp5jnb2s
24 Oct 23
Correspondence with SEC
12:00am
CORRESP
losxrb1xu37ygq513
24 Oct 23
Correspondence with SEC
12:00am
FWP
a1oa9l7e1u9l7nbs2okg
5 Oct 23
Free writing prospectus
5:05pm